Conclusion de contrats de coentreprise entre Shangai Zuquan Investment Management Company Limited d’une part et Epygon, Kephalios et MyoPowers d’autre part.
Recent Posts
- Carvolix is born and funded
- Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
- Caranx Medical (Carvolix project company) announces first clinical use in patients of the TAVIPILOT Robot at Macquarie University Hospital, Sydney, Australia
- Carvolix appoints Liane Teplitsky as a new member of the Board of Directors
-
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO
Recent Comments